PRE-PRINT EASY ACCESS
Disclaimer:
I am 2x Pfizer vaccinated, afterwards infected, my kids have been infected, their mother, their uncle, their grand mother. All after vaccination. I am
neither pro or anti vax. I am 100% pro choice.
But I am also pro transparency and I dispise how hard the media, the officials and the governments are making it for us to get to real data or
research, much less inform us about this research.
Therefore I see it as my duty to make an easy accessible list of pre-prints for you to spread around the world.
This post also does NOT, for now, care about Omicron, since it is still coming out as a variant that spreads easier, but is mild or asymptomatic,
which is good.
Remember, these are all pre-prints, and while that does not mean they are not true or accurate, it means they will be met with less open ears than
those articles that get groomed for print.
Pre-prints that discuss booster efficacy
Effectiveness of a third dose of BNT162b2 or mRNA-1273 vaccine for preventing post-vaccination COVID-19 infection: an observational study
www.medrxiv.org...
”Effectiveness of a third dose of BNT162b2 or mRNA-1273 compared to the primary series was 45.7% (95% confidence interval [CI]: 37.9-52.5%) and
46.6% (95% CI: 36.4-55.3%) for documented SARS-CoV-2 infection and 44.8% (95% CI: 26.6-58.4%) and 50.0% (95% CI: 26.2-66.1%) for COVID-19
hospitalization, respectively.”
Ad26.COV2.S or BNT162b2 Boosting of BNT162b2 Vaccinated Individuals
www.medrxiv.org...
Author comment: The researchers seem reluctant to posts results in the preview. You can head into the article itself and read the following: Booster
effect peaks after 2 weeks and starts waning after 4 weeks at levels MUCH lower than primary vaccination.
Pre-prints that discuss covid and kids
Risk of SARS-CoV-2 reinfections in children: prospective national surveillance, January 2020 to July 2021, England
www.medrxiv.org...
"Children had a lower risk of reinfection than adults, but reinfections were not associated with more severe disease or fatal outcomes."
SARS-CoV-2 and endemic coronaviruses: Comparing symptom presentation and severity of symptomatic illness among Nicaraguan children
www.medrxiv.org...
”This suggests that, for children, SARS-CoV-2 may be just another endemic coronavirus.”
Risk of Hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany
www.medrxiv.org...
”While the overall hospitalization rate associated with SARS-CoV-2 infection was 35.9 per 10,000 children, ICU admission rate was 1.7 per 10,000 and
case fatality was 0.09 per 10,000. Children without comorbidities were found to be significantly less likely to suffer from a severe or fatal disease
course.”
”Overall, the SARS-CoV-2-associated burden of a severe disease course or death in children and adolescents is low. This seems particularly the case
for 5-11-year-old children without comorbidities.”
Pre-prints that discuss general vaccine efficacy in hindsight
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with 3 BNT162b2
www.medrxiv.org...
Look at page 28 for titer numbers.
Adolescent vaccination with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine and effectiveness of the first dose against COVID-19: national test-negative
case-control study, England
www.medrxiv.org...
"VE against symptomatic disease increased to 80% within two weeks of the first dose of BNT162b2 vaccine (higher than in adults aged 18-64 years) and
then declines rapidly to 40% within 8 weeks (similar to adults)."
Reduced neutralisation of SARS-COV-2 Omicron-B.1.1.529 variant by post-immunisation serum
www.medrxiv.org...
”There was a substantial fall in neutralisation titres in recipients of both AZD1222 and BNT162b2 primary courses, with evidence of some recipients
failing to neutralise at all. This will likely lead to increased breakthrough infections in previously infected or double vaccinated individuals,
which could drive a further wave of infection, although there is currently no evidence of increased potential to cause severe disease, hospitalisation
or death.”
Investigation of Vaccine Breakthrough Infections by Vaccine strategy during the Delta Variant Wave in France
www.medrxiv.org...
”Our data emphasize a high prevalence of Delta-VBI occurring only one month after full immunization in young patients that might be related to
relaxation of barrier gestures.”
Author comment: Supposedly, as told by officials, our vaccine passports are green 14 days after full immunization (2nd jab)... were they wrong about
timing, or is the vaccine just poor?